EGFR and prostate carcinoma: As prostate cancer metastasises to the liver in over half of all patients with metastatic disease (Ewing, 1922; Shah et al, 2004), we sought to explore the correlative expression levels of EGFR and E-cadherin in the presence of parenchymal cells of the liver.